Abbott Diabetes Care is recalling certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus sensors due to falsely low glucose readings.

Discover some of the best medical device stocks to invest in, what makes them stand out, and key factors to consider before adding them to your portfolio.

Guadalupe Zuñiga has been around wrestling masks for as long as she can remember. It is a relationship that began when she watched her father performing in the ring and she has now transformed it into ...

This article discusses some of the best dividend stocks to consider buying right now.

American freestyle skiers are facing intense backlash on social media after comments made about representing the United States at the 2026 Milan Cortina Winter Olympics amid the Trump administration’s ...

Mac Forehand is looking to reach new heights — and perhaps the Olympic podium — this winter. The next step of that career brings him to Italy, where he will chase his first ever Olympic medal at the ...

A fierce competition is shaping up in men’s freestyle skiing slopestyle at the Olympic Winter Games Milano Cortina 2026, with gold to be decided at Livigno Snow Park among one of the deepest fields in ...

Abbott is facing a warning letter from FDA regarding its Freestyle Libre family of continuous glucose monitoring (CGM) devices for use in diabetes management. The agency said it received responses ...

Abbott has been hit with a slew of complaints from the FDA in a warning letter related to its continuous glucose monitor (CGM) franchise, FreeStyle Libre. Last October, an agency inspection of ...

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Abbott Laboratories (NYSE:ABT) received an FDA warning ...